Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (HER2+BC) represents approximately 15–20% of all breast tumors and is associated with aggressive behavior and poor prognosis [1]. This evidence concerns the gene ERBB2 and breast carcinoma.